| Company | Ticker | Brokerage Firm | Ratings Change | Price Target |
| Monsanto | MON | Deutsche Bank | Hold » Buy | $75 » $78 |
| Telesp Part Adr | TSP | Barclays Capital | Underweight » Overweight | $22 » $28 |
| Beazer Homes | BZH | UBS | Neutral » Buy | $6 » $6 |
| Georgia Gulf | GGC | BB&T Capital Mkts | Hold » Buy |
|
| Intel | INTC | Standpoint Research | Hold » Buy | $24 |
| Symantec | SYMC | RBC Capital Mkts | Sector Perform » Outperform | $20 » $23 |
| Zumiez | ZUMZ | Wedbush | Underperform » Neutral | $25 |
| Liberty Prop | LRY | Stifel Nicolaus | Hold » Buy | $35.50 |
| CommonWealth REIT | CWH | Stifel Nicolaus | Sell » Hold |
|
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target |
| National Semi | NSM | Deutsche Bank | Buy » Hold | $17 » $25 |
| Medivation | MDVN | Rodman & Renshaw | Mkt Perform » Mkt Underperform |
|
| Telesp Part Adr | TSP | Standpoint Research | Buy » Hold |
|
| Energizer | ENR | UBS | Buy » Neutral | $78 » $76 |
| IBM | IBM | Canaccord Genuity | Buy » Hold | $180 |
| Tortoise Capital | TTO | Ladenburg Thalmann | Buy » Neutral |
|
| Arch Chemicals | ARJ | BB&T Capital Mkts | Buy » Hold |
|
| Advance Auto | AAP | BB&T Capital Mkts | Buy » Hold |
|
| AutoZone | AZO | BB&T Capital Mkts | Buy » Hold |
|
| Charter Comm | CHTR | Miller Tabak | Buy » Hold |
|
| Cinemark | CNK | Caris & Company | Above Average » Average |
|
| Novellus | NVLS | RBC Capital Mkts | Top Pick » Outperform | $42 » $38 |
| Copa Holdings | CPA | Dahlman Rose | Buy » Hold |
|
| Republic Airways | RJET | Dahlman Rose | Buy » Hold |
|
| Hawaiian Holdings | HA | Dahlman Rose | Buy » Hold |
|
| United Continental | UAL | Dahlman Rose | Buy » Hold |
|
| US Airways | LCC | Dahlman Rose | Buy » Hold |
|
| Delta Air Lines | DAL | Dahlman Rose | Buy » Hold |
|
| Jetblue Airways | JBLU | Dahlman Rose | Hold » Sell | $5 |
| AMR | AMR | Dahlman Rose | Hold » Sell | $4.50 |
| HeartWare | HTWR | Auriga U.S.A | Buy » Hold | $101 » $80 |
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target |
| Webster Financial | WBS | Boenning & Scattergood | Outperform | $27 |
| Summit Hotel | INN | KeyBanc Capital Mkts | Buy | $13 |
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target |
| Savient Pharma | SVNT | Wedbush | Outperform | $15 |
Coverage Reit/Price Tgt Changed*
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target |
| ADA-ES | ADES | JMP Securities | Mkt Outperform | $24 » $17 |
| Chevron | CVX | Deutsche Bank | Hold | $105 » $115 |
| Murphy Oil | MUR | Deutsche Bank | Hold | $80 » $85 |
| Hess | HES | Deutsche Bank | Buy | $96 » $105 |
| Waters | WAT | Barclays Capital | Overweight | $90 » $95 |
| TIM Participacoes | TSU | Barclays Capital | Equal Weight | $39 » $46 |
| Gen-Probe | GPRO | Barclays Capital | Overweight | $65 » $70 |
| Bancolombia S.A. | CIB | Barclays Capital | Underweight | $54 » $57 |
| Agilent | A | Barclays Capital | Overweight | $50 » $54 |
| A123 Systems | AONE | Barclays Capital | Overweight | $12 » $11 |
| V.F. Corp | VFC | UBS | Buy | $98 » $109 |
| Valeant Pharmaceuticals | VRX | UBS | Buy | $46 » $63 |
| Perrigo | PRGO | UBS | Buy | $82 » $92 |
| Dolby Labs | DLB | Miller Tabak | Hold | $57 » $70 |
| Andersons | ANDE | Feltl & Co. | Buy | $54.50 » $59.60 |
| Cracker Barrel | CBRL | Miller Tabak | Buy | $67 » $64 |
| Allied Nevada | ANV | Dahlman Rose | Buy | $43.11 » $54.90 |
| Fortinet | FTNT | RBC Capital Mkts | Outperform | $40 » $44 |
| Check Point Software | CHKP | RBC Capital Mkts | Outperform | $50 » $60 |
| Hansen Natural | HANS | Stifel Nicolaus | Buy | $65 » $67 |
| Interactive Intelligence | ININ | Northland Securities | Outperform | $38 » $46 |
| Yingli Green Energy | YGE | Auriga U.S.A | Buy | $18 » $14.50 |
| Questcor Pharma | QCOR | Oppenheimer | Outperform | $19 » $23 |
| Valero Energy | VLO | The Benchmark Company | Buy | $27 » $31 |
| Comcast | CMCSA | Wunderlich | Buy | $30 » $33 |
(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.
(b) Brokerage firm resumes coverage.
(c) Brokerage firm participated in the secondary offering.
* This list of reiterations/target changes is not comprehensive.
No comments:
Post a Comment